Related Experiment Video
Updated: Dec 20, 2025
Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Short term methylphenidate treatment does not increase myocardial injury in the ischemic rat heart
S L Seeley1, M S D'Souza, T S Stoops
1Marshall University School of Pharmacy, Huntington, WV, USA. rorabaughb@marshall.edu.
Abstract:
Methylphenidate is commonly used for the treatment of attention deficit hyperactivity disorder. The cardiovascular safety of methylphenidate has been a subject of debate with some studies indicating that methylphenidate increases the likelihood of experiencing a myocardial infarction. However, it is unknown whether methylphenidate worsens the extent of injury during an ischemic insult. The purpose of this study was to determine whether short term exposure to methylphenidate increases the extent of myocardial injury during an ischemic insult. Male and female rats received methylphenidate (5 mg/kg/day) or saline for 10 days by oral gavage. Hearts were subjected to 20 min of ischemia and 2 h of reperfusion on a Langendorff isolated heart apparatus on day 11. Cardiac contractile function was monitored via an intraventricular balloon and myocardial injury was assessed by triphenyltetrazolium chloride staining. Methylphenidate significantly increased locomotor activity in male and female rats, confirming absorption of this psychostimulant into the central nervous system. Male hearts had significantly larger infarcts than female hearts, but methylphenidate had no impact on infarct size or postischemic recovery of contractile function in hearts of either sex. These data indicate that methylphenidate does not increase the extent of injury induced by an ischemic insult.
Insights
Methylphenidate, used for attention deficit hyperactivity disorder, does not worsen heart injury during ischemia. This study found no increase in myocardial damage or impaired recovery after ischemic events in rats treated with methylphenidate.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Toxicology
Background:
- Methylphenidate is a common treatment for attention deficit hyperactivity disorder (ADHD).
- Concerns exist regarding methylphenidate's cardiovascular safety, particularly its potential to increase myocardial infarction risk.
- The effect of methylphenidate on the extent of myocardial injury following ischemic events remains unclear.
Purpose of the Study:
- To investigate whether short-term methylphenidate exposure exacerbates myocardial injury during an ischemic insult.
- To determine the impact of methylphenidate on infarct size and cardiac function recovery after ischemia-reperfusion.
Main Methods:
- Male and female rats were administered methylphenidate (5 mg/kg/day) or saline orally for 10 days.
- Hearts were subjected to 20 minutes of ischemia followed by 2 hours of reperfusion using a Langendorff apparatus.
- Cardiac function was assessed using an intraventricular balloon, and myocardial injury was quantified by triphenyltetrazolium chloride staining.
Main Results:
- Methylphenidate administration confirmed central nervous system absorption by significantly increasing locomotor activity in both sexes.
- Male rat hearts exhibited significantly larger infarct sizes compared to female rat hearts.
- Methylphenidate treatment did not significantly alter infarct size or the recovery of contractile function in hearts of either sex following ischemia-reperfusion.
Conclusions:
- Short-term methylphenidate exposure does not increase the extent of myocardial injury induced by an ischemic insult.
- The study suggests that methylphenidate does not negatively impact cardiac recovery post-ischemia.
- These findings contribute to understanding the cardiovascular safety profile of methylphenidate in the context of ischemic events.
